TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jacomm /Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,154
|
1,204
|
1,184 |
Financial expenses |
7
|
4
![]() |
4 |
Earnings before taxes |
-20
|
79
|
36 |
EBITDA |
-14
|
84
|
41 |
Total assets |
486
|
478
|
454 |
Current assets |
481
|
477
|
452 |
Current liabilities |
309
|
189
|
204 |
Equity capital |
91
|
197
|
146 |
- share capital |
5
|
4
|
5 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
18.7%
|
41.2%
|
32.2% |
Turnover per employee |
385
|
401
|
395 |
Profit as a percentage of turnover |
-1.7%
|
6.6%
|
3.0% |
Return on assets (ROA) |
-2.7%
|
17.4%
|
8.8% |
Current ratio |
155.7%
|
252.4%
|
221.6% |
Return on equity (ROE) |
-22.0%
|
40.1%
|
24.7% |
Change turnover |
-53
|
116
|
43 |
Change turnover % |
-4%
|
11%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.